G1 Therapeutics, Inc. (GTHX)

G1 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	32.47	94.91	221.56	207.81	269.71
Short-Term Investments	49.94	50.48	0	0	0
Cash & Cash Equivalents	82.41	145.38	221.56	207.81	269.71
Cash Growth	-43.32%	-34.38%	6.62%	-22.95%	-26.97%
Receivables	12.69	11.09	5.69	0.24	0
Inventory	12.44	16.18	3.47	0	0
Other Current Assets	7.41	6.84	12.85	8.35	1.3
Total Current Assets	114.95	179.5	243.57	216.39	271
Property, Plant & Equipment	6.38	7.95	9.05	10.51	13.39
Other Long-Term Assets	0.21	0.51	1.48	1.65	0.44
Total Long-Term Assets	6.59	8.47	10.53	12.16	13.83
Total Assets	121.54	187.97	254.09	228.55	284.83
Accounts Payable	3.99	7.43	2.9	3.57	3.68
Deferred Revenue	1.12	1.01	1.03	0.24	0
Other Current Liabilities	24.6	27.15	23.69	19.63	16.09
Total Current Liabilities	29.72	35.59	27.61	23.44	19.77
Long-Term Debt	55.9	82.63	81.94	27.76	9.54
Other Long-Term Liabilities	0.54	1	1	0	0
Total Long-Term Liabilities	56.44	83.63	82.94	27.76	9.54
Total Liabilities	86.15	119.22	110.55	51.2	29.3
Total Debt	55.9	82.63	81.94	27.76	9.54
Debt Growth	-32.35%	0.84%	195.19%	191.12%	-
Retained Earnings	-779.99	-732.02	-584.46	-436.11	-336.85
Shareholders' Equity	35.39	68.75	143.54	177.35	255.53
Net Cash / Debt	26.51	62.75	139.62	180.05	260.17
Net Cash / Debt Growth	-57.76%	-55.05%	-22.45%	-30.80%	-29.55%
Net Cash Per Share	0.51	1.44	3.33	4.75	6.94
Working Capital	85.23	143.91	215.95	192.95	251.23
Book Value Per Share	0.68	1.58	3.42	4.68	6.81

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).